Professor Johnjoe McFadden
Professor of Molecular Genetics
Qualifications: BSc (Biochemistry), PhD (Biochemistry)
Email: j.mcfadden@surrey.ac.uk
Phone: Work: 01483 68 6494
Room no: 07 AX 01
Further information
Biography
2002 – present, . Professor of Molecular Genetics, University of Surrey
1994 – 2001 Reader, School of Biological Sciences, University of Surrey.
1988-94 Lecturer, School of Biological Sciences, University of Surrey.
1984-88 Research Fellow. Department of Surgery, St. George's Hospital Medical School, London.
1982-84 Research Fellow, Department of Biochemistry, St. Mary's Hospital Medical School, London.
1982: PhD (Biochemistry) Imperial College, University of London
1978 BSc (Biochemistry) Bedford College, University of London
Research Interests
Systems Biology
Mycobacterial genetics
Pathogenicity of tuberculosis
Neisserial genetics
Pathogenicity of meningococcal meningitis
Bionanotechnology
Research Collaborations
CARBIO network: Marie Curie Research Training Network - Multifunctional Carbon Nanotubes for Biomedical Applications
Publications
Highlights
- .
(2011) '¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.'. PLoS PLoS Pathog, United States: 7 (7)Full text is available at: http://epubs.surrey.ac.uk/184899/
Journal articles
- .
(2012) 'Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes'. Carbon, Full text is available at: http://epubs.surrey.ac.uk/7905/
- .
(2011) 'Chloroquine-enhanced gene delivery mediated by carbon nanotubes'. Elsevier Carbon, 49 (15), pp. 5348-5358.Full text is available at: http://epubs.surrey.ac.uk/7815/
- .
(2011) '¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.'. PLoS PLoS Pathog, United States: 7 (7)Full text is available at: http://epubs.surrey.ac.uk/184899/
- .
(2011) 'Differential Producibility Analysis (DPA) of Transcriptomic Data with Metabolic Networks: Deconstructing the Metabolic Response of M. tuberculosis'. PUBLIC LIBRARY SCIENCE PLOS COMPUT BIOL, 7 (6) Article number e1002060 Full text is available at: http://epubs.surrey.ac.uk/184902/
- .
(2011) 'Optimising DNA binding to carbon nanotubes by non-covalent methods'. PERGAMON-ELSEVIER SCIENCE LTD CARBON, 49 (5), pp. 1775-1781.Full text is available at: http://epubs.surrey.ac.uk/7818/
- .
(2011) 'Acorn: a grid computing system for constraint based modeling and visualization of the genome scale metabolic reaction networks via a web interface.'. BMC Bioinformatics, England: 12Full text is available at: http://epubs.surrey.ac.uk/185976/
- . (2010) 'Carbon flux rerouting during Mycobacterium tuberculosis growth arrest'. WILEY-BLACKWELL PUBLISHING, INC MOL MICROBIOL, 78 (5), pp. 1199-1215.
- .
(2010) 'Modeling and simulation of the main metabolism in Escherichia coli and its several single-gene knockout mutants with experimental verification'. BIOMED CENTRAL LTD MICROB CELL FACT, 9 Article number 88 Full text is available at: http://epubs.surrey.ac.uk/239125/
- .
(2010) 'Systems biology of the metabolism of Mycobacterium tuberculosis'. PORTLAND PRESS LTD Biochemical Society Transactions, 38 (5), pp. 1286-1289.doi: 10.1042/BST0381286Full text is available at: http://epubs.surrey.ac.uk/184901/
- .
(2010) 'Physics and the mind Comment on 'Natural world physical-, brain operational-, and mind phenomenal-space-time' by Fingelkurts et al.'. ELSEVIER SCIENCE BV PHYS LIFE REV, 7 (2), pp. 250-251.Full text is available at: http://epubs.surrey.ac.uk/7370/
- .
(2010) 'Higher Dispersion Efficacy of Functionalized Carbon Nanotubes in Chemical and Biological Environments'. AMER CHEMICAL SOC ACS NANO, 4 (5), pp. 2615-2626.doi: 10.1021/nn100069kFull text is available at: http://epubs.surrey.ac.uk/7323/
- . (2010) 'Uptake and Release of Double-Walled Carbon Nanotubes by Mammalian Cells'. WILEY-V C H VERLAG GMBH ADV FUNCT MATER, 20 (19), pp. 3272-3279.
- .
(2010) 'System-level strategies for studying the metabolism of Mycobacterium tuberculosis'. ROYAL SOC CHEMISTRY MOL BIOSYST, 6 (12), pp. 2363-2372.doi: 10.1039/c003757pFull text is available at: http://epubs.surrey.ac.uk/184934/
- .
(2009) 'Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS'. Elsevier TUBERCULOSIS, 89 (6), pp. 423-430.Full text is available at: http://epubs.surrey.ac.uk/7319/
- . (2009) 'AFM imaging of functionalized carbon nanotubes on biological membranes'. IOP PUBLISHING LTD NANOTECHNOLOGY, 20 (43) Article number 434001
- .
(2009) 'Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy'. PERGAMON-ELSEVIER SCIENCE LTD CARBON, 47 (9), pp. 2152-2160.Full text is available at: http://epubs.surrey.ac.uk/7324/
- .
(2009) 'The Genetic Requirements for Fast and Slow Growth in Mycobacteria'. PUBLIC LIBRARY SCIENCE PLOS ONE, 4 (4) Article number e5349 Full text is available at: http://epubs.surrey.ac.uk/184900/
- .
(2009) 'Towards the Immunoproteome of Neisseria meningitidis'. PUBLIC LIBRARY SCIENCE PLOS ONE, 4 (6) Article number e5940 Full text is available at: http://epubs.surrey.ac.uk/2561/
- . (2008) 'Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice'. SOC GENERAL MICROBIOLOGY J MED MICROBIOL, 57 (2), pp. 164-170.
- .
(2008) 'The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes'. AMER SOC MICROBIOLOGY INFECT IMMUN, 76 (3), pp. 1298-1304.doi: 10.1128/IAI.00741-07Full text is available at: http://epubs.surrey.ac.uk/351097/
- . (2007) 'Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG'. CHURCHILL LIVINGSTONE TUBERCULOSIS, 87 (6), pp. 474-480.
- .
(2007) 'Transcriptomic analysis identifies growth rate modulation as a component of the adaptation of mycobacteria to survival inside the macrophage'. AMER SOC MICROBIOLOGY J BACTERIOL, 189 (11), pp. 3969-3976.doi: 10.1128/JB.01787-06Full text is available at: http://epubs.surrey.ac.uk/184935/
- . (2007) 'Mycobacterium bovis BCG as a delivery system for the RAP-1 antigen from Babesia bovis'. ELSEVIER SCI LTD VACCINE, 25 (6), pp. 1104-1113.
- .
(2007) 'GSMN-TB: a web-based genome scale network model of Mycobacterium tuberculosis metabolism'. BIOMED CENTRAL LTD GENOME BIOL, 8 (5) Article number r89 Full text is available at: http://epubs.surrey.ac.uk/184904/
- . (2006) 'Immunogenicity of Mycobacterium bovis BCG expressing Anaplasma marginale MSP1a antigen'. ELSEVIER SCI LTD VACCINE, 24 (37-39), pp. 6332-6339.
- . (2006) 'Generation of chemically unmodified pure single-walled carbon nanotubes by solubilizing with RNA and treatment with ribonuclease A'. WILEY-V C H VERLAG GMBH ADV MATER, 18 (12), pp. 1598-+.
- . (2006) 'Reduced toxicity of lipo-oligosaccharide from a phoP mutant of Neisseria meningitidis: an in vitro demonstration'. MANEY PUBLISHING J ENDOTOXIN RES, 12 (1), pp. 39-46.
Conference papers
- . (2008) 'Dendritic cell responses to C-reactive protein-opsonised Neisseria meningitidis'. WILEY-BLACKWELL PUBLISHING, INC IMMUNOLOGY, Glasgow, SCOTLAND: Annual Congress of the British-Society-of-Immunology 125, pp. 124-124.
- . (2007) 'C-reactive protein binds to Neisseria meningitidis and affects macrophage responses to infection'. BLACKWELL PUBLISHING IMMUNOLOGY, Glasgow, SCOTLAND: Annual Congress of the British-Society-of-Immunology 120, pp. 20-20.
Mycobacterial research
The tubercle bacillus (Mycobacterium tuberculosis) infects approximately one quarter of the world's population and is responsible for three million deaths each year.
Mycobacterial research within the Microbial Sciences Group is focussed on understanding the pathogenic mechanisms that allow Mycobacterium tuberculosis to cause about three million deaths each year, and development of new vaccines to treat the disease.
We have recently initiated a new BBSRC-funded project to develop metabolic models of the TB bacillus and use these models to predict novel drug targets, particularly in persistent organisms. A web version of our model can be found here.
We currently have a Wellcome Trust-funded vacancy (to start autumn 2009) for a bioinformaticist to develop metabolic models of the TB bacillus.
Meningococcal research

